WGS (Sema4) Sotuvning yalpi marjinal rentabelligi

Sema4 (WGS) kompaniyasining rasmiy ramzlari

GeneDx Holdings Corp. klinika va sog'liqni saqlash gigantlari bilan hamkorlik orqali o'z mavqeini mustahkamlamoqda hamda noyob patologiyalarni tashxislashda sinergiya yaratmoqda. Yalpi foyda rentabelligi ushbu o'sishni tasdiqlaydi, joriy daraja esa 65.00 atrofida shakllangan. Biznes AI asosidagi ekzom tahlili orqali nishadagi ustunlikka intilmoqda, kompaniyaning noyob genetik ma'lumotlar to'plami esa u uchun kuchli raqobatbardoshlik asosini tashkil etadi.

WGS genedx.com Yalpi foyda bo'yicha rentabellik (28.04.2023 - 20.11.2026)

GeneDx Holdings (WGS) kompaniyasining tahliliy kesimlari va maʼlumotlar hisoboti

- kotirovkalar va tahlilchilar prognozi:
Kompaniyaning asosiy tahlili:GeneDx Holdings (WGS)
GeneDx asosiy tovari

GeneDx Holdings Corp. (WGS) kompaniyasida testlarni avtomatlashtirish va reagentlar iste'molini optimallashtirish sotilgan tovarlar tannarxini bevosita kamaytiradi, bu esa yalpi foyda marjasi tendentsiyasida aks etadi. Ushbu metrika operatsion xarajatlargacha bo'lgan ishlab chiqarish samaradorligini o'lchaydi, bu esa investorlarga biznesning fundamental daromadliligini va kompaniyaning marja barqarorligiga tegishli bozor konsensusini baholash uchun ushbu ko'rsatkichni tahlil qilish imkonini beradi.

Asosiy raqobatchilar

Yalpi foyda bo'yicha rentabellik Tempus AI Inc|QGEN (Qiagen NV) - Yalpi marja|Yalpi foyda bo'yicha rentabellik Ionis Pharma (IONS)|Yalpi rentabellik Repligen Corp (RGEN)|RNA - Yalpi foyda marjasi|crisprtx.com - Yalpi foyda bo'yicha rentabellik|Yalpi foyda normasi RARE|Beam Tx - Yalpi marja|SRPT - Yalpi marja|TWST (Twist Bio) - Yalpi foyda bo'yicha rentabellik|Sotuvning yalpi rentabelligi TXG|Yalpi foyda bo'yicha rentabellik NTLA|Stoke Therapeutics Inc (STOK) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi marja BLFS|Yalpi rentabellik WVE (Wave Life Sciences Corp)|Yalpi rentabellik Maze Therapeutics MAZE|Yalpi foyda normasi SION|PRME - Yalpi rentabellik|Yalpi foyda bo'yicha sotuv rentabelligi Taysha TSHA|QURE: Yalpi marja|Yalpi foyda bo'yicha rentabellik MeiraGTx PLC|RGNX (REGENXBIO Inc) - Yalpi marja|solidbio.com (SLDB) - Yalpi foyda bo'yicha sotuv rentabelligi|Yalpi rentabellik Ocugen Corp (OCGN)|Pacific Biosciences of California, Inc. - Sotuvning yalpi rentabelligi|Benitec Biopharma - Yalpi foyda bo'yicha rentabellik|DSGN: Sotuvning yalpi rentabelligi|RCKT: Yalpi foyda bo'yicha rentabellik|FDMT - Yalpi marja|LXEO: Yalpi marja|Korro Bio Inc. - Yalpi foyda normasi|EDIT (editasmedicine.com) - Yalpi marja|Yalpi rentabellik SLN|Yalpi rentabellik ProQR Therapeutics NV (PRQR)|Codexis - Sotuvning yalpi rentabelligi|Yalpi rentabellik Sangamo SGMO|NAUT: Sotuvning yalpi rentabelligi|MGX: Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi Precision BioSciences|GBIO (generationbio.com) - Yalpi foyda bo'yicha rentabellik|Yalpi foyda marjasi boundlessbio.com (BOLD)|XCUR (exicuretx.com) - Yalpi marja|Sotuvning yalpi rentabelligi IMNN (Imunon, Inc.)|Yalpi marja PHIO|MBIO - Yalpi foyda marjasi|Yalpi marja RNAZ (TransCode Therapeutics)|bionanogenomics.com (BNGO) - Yalpi foyda marjasi|Applied DNA - Yalpi marja|Yalpi foyda marjasi Bluebird Bio|ImmunoPrecise (IPA) - Yalpi rentabellik|Yalpi foyda bo'yicha marjinallik OMGA (Omega)|Yalpi rentabellik Singular Genomics Systems|Yalpi foyda marjasi regulusrx.com RGLS|Yalpi rentabellik Syros Pharmaceuticals Inc. (SYRS)|Yalpi foyda bo'yicha sotuv rentabelligi Codex DNA|Yalpi rentabellik TRACON TCON|Unity Biotechnology, Inc - Yalpi rentabellik